BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21428958)

  • 1. The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPL.
    McKeen HD; Brennan DJ; Hegarty S; Lanigan F; Jirstrom K; Byrne C; Yakkundi A; McCarthy HO; Gallagher WM; Robson T
    Biochem Soc Trans; 2011 Apr; 39(2):663-8. PubMed ID: 21428958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling.
    McKeen HD; McAlpine K; Valentine A; Quinn DJ; McClelland K; Byrne C; O'Rourke M; Young S; Scott CJ; McCarthy HO; Hirst DG; Robson T
    Endocrinology; 2008 Nov; 149(11):5724-34. PubMed ID: 18669603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic and diagnostic potential of FKBPL; a novel anticancer protein.
    Robson T; James IF
    Drug Discov Today; 2012 Jun; 17(11-12):544-8. PubMed ID: 22265918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of the Hsp90-Binding FKBP Immunophilins.
    Ortiz NR; Guy N; Garcia YA; Sivils JC; Galigniana MD; Cox MB
    Subcell Biochem; 2023; 101():41-80. PubMed ID: 36520303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy.
    McKeen HD; Byrne C; Jithesh PV; Donley C; Valentine A; Yakkundi A; O'Rourke M; Swanton C; McCarthy HO; Hirst DG; Robson T
    Cancer Res; 2010 Feb; 70(3):1090-100. PubMed ID: 20103631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FKBP family proteins: immunophilins with versatile biological functions.
    Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
    Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction of immunophilin FKBP and intracellular Ca2+ release channels].
    Onoe H; Itonaga Y; Ito Y
    Fukuoka Igaku Zasshi; 2001 Jul; 92(7):272-7. PubMed ID: 11681278
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen.
    Donley C; McClelland K; McKeen HD; Nelson L; Yakkundi A; Jithesh PV; Burrows J; McClements L; Valentine A; Prise KM; McCarthy HO; Robson T
    Oncogene; 2014 Jun; 33(26):3441-50. PubMed ID: 23912458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All of the protein interactions that link steroid receptor.hsp90.immunophilin heterocomplexes to cytoplasmic dynein are common to plant and animal cells.
    Harrell JM; Kurek I; Breiman A; Radanyi C; Renoir JM; Pratt WB; Galigniana MD
    Biochemistry; 2002 Apr; 41(17):5581-7. PubMed ID: 11969419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic roles in cancer biology for multifaceted proteins FKBPs.
    Romano S; D'Angelillo A; Romano MF
    Biochim Biophys Acta; 2015 Oct; 1850(10):2061-8. PubMed ID: 25592270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functions of the Hsp90-binding FKBP immunophilins.
    Guy NC; Garcia YA; Sivils JC; Galigniana MD; Cox MB
    Subcell Biochem; 2015; 78():35-68. PubMed ID: 25487015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FKBPL: a marker of good prognosis in breast cancer.
    Nelson L; McKeen HD; Marshall A; Mulrane L; Starczynski J; Storr SJ; Lanigan F; Byrne C; Arthur K; Hegarty S; Ali AA; Furlong F; McCarthy HO; Ellis IO; Green AR; Rakha E; Young L; Kunkler I; Thomas J; Jack W; Cameron D; Jirström K; Yakkundi A; McClements L; Martin SG; Gallagher WM; Dunn J; Bartlett J; O'Connor D; Robson T
    Oncotarget; 2015 May; 6(14):12209-23. PubMed ID: 25906750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophilin chaperones in steroid receptor signalling.
    Ratajczak T; Ward BK; Minchin RF
    Curr Top Med Chem; 2003; 3(12):1348-57. PubMed ID: 12871166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FKBP immunophilins and Alzheimer's disease: a chaperoned affair.
    Cao W; Konsolaki M
    J Biosci; 2011 Aug; 36(3):493-8. PubMed ID: 21799260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506.
    Gold BG; Densmore V; Shou W; Matzuk MM; Gordon HS
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1202-10. PubMed ID: 10336507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK506 and the role of immunophilins in nerve regeneration.
    Gold BG
    Mol Neurobiol; 1997 Dec; 15(3):285-306. PubMed ID: 9457703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis.
    Yakkundi A; Bennett R; Hernández-Negrete I; Delalande JM; Hanna M; Lyubomska O; Arthur K; Short A; McKeen H; Nelson L; McCrudden CM; McNally R; McClements L; McCarthy HO; Burns AJ; Bicknell R; Kissenpfennig A; Robson T
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):845-54. PubMed ID: 25767277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological intervention.
    Annett S; Moore G; Robson T
    Pharmacol Ther; 2020 Nov; 215():107623. PubMed ID: 32622856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of FKBP associated protein 48 (FAP48) at proline 219 disrupts the interaction with FKBP12 and FKBP52.
    Neye H
    Regul Pept; 2001 Mar; 97(2-3):147-52. PubMed ID: 11164950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of FKBP5 in cancer aetiology and chemoresistance.
    Li L; Lou Z; Wang L
    Br J Cancer; 2011 Jan; 104(1):19-23. PubMed ID: 21119664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.